These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12573816)

  • 61. Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.
    Popovics P; Cai R; Sha W; Rick FG; Schally AV
    Prostate; 2018 Sep; 78(13):970-980. PubMed ID: 29786867
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
    Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia.
    Gleason PE; Jones JA; Regan JS; Salvas DB; Eble JN; Lamph WW; Vlahos CJ; Huang WL; Falcone JF; Hirsch KS
    J Urol; 1993 Jun; 149(6):1586-92. PubMed ID: 7684794
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human bladder as a novel target for vitamin D receptor ligands.
    Crescioli C; Morelli A; Adorini L; Ferruzzi P; Luconi M; Vannelli GB; Marini M; Gelmini S; Fibbi B; Donati S; Villari D; Forti G; Colli E; Andersson KE; Maggi M
    J Clin Endocrinol Metab; 2005 Feb; 90(2):962-72. PubMed ID: 15572423
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chinese Skullcap (Scutellaria baicalensis Georgi) inhibits inflammation and proliferation on benign prostatic hyperplasia in rats.
    Jin BR; Chung KS; Kim HJ; An HJ
    J Ethnopharmacol; 2019 May; 235():481-488. PubMed ID: 30708034
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.
    Erdoğru T; Ciftcioglu MA; Emreoglu I; Usta MF; Koksal T; Ozbilim G; Gulkesen KH; Baykara M
    Urol Int; 2002; 69(4):287-92. PubMed ID: 12444285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Luo F; Zhou Y; Du X; Shi J; Zhao X; Xu Y; Zhu Y; Hong W; Zhang J
    Exp Cell Res; 2016 Jul; 345(2):125-33. PubMed ID: 25849092
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An investigation on the relevance of prolactin, insulin-like growth factor-1 and 25-hydroxyvitamin D
    Werhahn Beining F; Schmicke M; Wilkens M; Wolf K; Rohn K; Günzel-Apel AR
    Vet Med Sci; 2021 Sep; 7(5):1493-1503. PubMed ID: 34015193
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
    Fiorelli G; De Bellis A; Longo A; Giannini S; Natali A; Costantini A; Vannelli GB; Serio M
    J Clin Endocrinol Metab; 1991 Apr; 72(4):740-6. PubMed ID: 1848565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
    Ho CK; Nanda J; Chapman KE; Habib FK
    J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insulin-like growth factors and risk of benign prostatic hyperplasia.
    Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Prostate; 2002 Jul; 52(2):98-105. PubMed ID: 12111701
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study.
    Tang J; Yang JC; Zhang Y; Liu X; Zhang L; Wang Z; Li J; Luo Y; Xu J; Shi H
    BJU Int; 2007 Nov; 100(5):1091-6. PubMed ID: 17922787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6.
    Degeorges A; Tatoud R; Fauvel-Lafeve F; Podgorniak MP; Millot G; de Cremoux P; Calvo F
    Int J Cancer; 1996 Oct; 68(2):207-14. PubMed ID: 8900430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Red clover isoflavones inhibit the proliferation and promote the apoptosis of benign prostatic hyperplasia stromal cells].
    Chen MY; Yan SC; Yin CP; Ye L; Zhang MK; Yang J; Liu JH
    Zhonghua Nan Ke Xue; 2010 Jan; 16(1):34-9. PubMed ID: 20180402
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of cyclic stretch on prostatic cells in culture.
    Hegarty PK; Watson RW; Coffey RN; Webber MM; Fitzpatrick JM
    J Urol; 2002 Nov; 168(5):2291-5. PubMed ID: 12394777
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
    Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
    Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells.
    Liu X; Allen JD; Arnold JT; Blackman MR
    Carcinogenesis; 2008 Apr; 29(4):816-23. PubMed ID: 18283040
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.
    Mesiano S; Katz SL; Lee JY; Jaffe RB
    J Clin Endocrinol Metab; 1997 May; 82(5):1390-6. PubMed ID: 9141522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.